Governance Bristol-Myers Squibb Company

BMY

US1101221083

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 01:31:35 2026-04-22 pm EDT			5-day change	1st Jan Change
58.85 ^USD	-0.91%		+1.55%	+8.99%

11:10am	UBS Group Still 'Strongly' Disagrees With Swiss Federal Council's Updated Capital Rules	MT
Apr. 21	Foundation Medicine Broadens Bristol Myers Squibb Collaboration for MTAP Biomarker Testing	MT

Executive Committee: Bristol-Myers Squibb Company

Manager

Positions heldSince

Christopher Boerner

55 year

Chief Executive Officer

2023-10-31

Karin Shanahan

61 year

Chief Operating Officer

2021-12-31

Amy Fallone

Corporate Secretary

2024-03-31

Phil Holzer

50 year

Comptroller/Controller/Auditor

2014-12-31

Amanda Poole

51 year

Human Resources Officer

2023-12-31

Robert Plenge

55 year

Chief Tech/Sci/R&D Officer

2019-10-31

Greg Meyers

53 year

Chief Tech/Sci/R&D Officer

2021-12-31

Cari Gallman

46 year

General Counsel

2025-05-04

David Elkins

58 year

Director of Finance/CFO

2019-11-19

Cristian Massacesi

57 year

Chief Tech/Sci/R&D Officer

2025-07-31

Composition of the Board of Directors: Bristol-Myers Squibb Company

Director

CommitteesSince

Christopher Boerner

55 year

Chairman

2024-03-31

Theodore Samuels

71 year

Audit Committee	2017-02-20
Governance Committee Chair	2023-07-16
Compensation Committee	2021-12-31
Governance Committee	2021-12-31
Finance Committee	2023-07-16
Nominating Committee Chair	2023-07-16

Paula Price

64 year

Compensation Committee	2014-05-08
HR Committee	2014-05-08
Audit Committee Chair	2021-12-31
Audit Committee
Governance Committee
Finance Committee

Derica Rice

61 year

Audit Committee Chair
Compensation Committee
Audit Committee	2021-07-21
Finance Committee	2020-08-30

Michael McMullen

65 year

HR Committee	2023-07-23
Compensation Committee Chair	2025-11-04
Audit Committee	2024-06-30
Compensation Committee

Phyllis Yale

68 year

Governance Committee Chair	2016-07-10
Nominating Committee Chair	2016-07-10
Audit Committee

Manuel Medina

58 year

Governance Committee	2024-07-16
Nominating Committee	2024-07-16

Karen Vousden

68 year

Compensation Committee

2017-12-31

Julia Haller

71 year

Governance Committee

Deepak Bhatt

58 year

Compensation Committee

2022-06-13

Peter Arduini

61 year

Compensation Committee Chair

Latest Appointments: Bristol-Myers Squibb Company

Apr. 02	Coya Therapeutics, Inc. Announces Board Changes, Effective as of April 1, 2026	CI
Apr. 01	Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment	CI
Mar. 23	Insitro And Bristol Myers Squibb Expand Collaboration With Nomination Of New Targets	CI
Mar. 09	Global markets live: Live Nation, Eli Lilly, Amazon, Microsoft, ABB…
Mar. 06	Novartis Shareholders Approve Dividend Raise, Share Capital Reduction	MT
Mar. 06	Novartis Shareholders Re-elect Board Chair	MT
Mar. 03	Protagenic Therapeutics, Inc. Appoints William Nichols as President, Effective February 3, 2026	CI

More news

Former Officers and Directors: Bristol-Myers Squibb Company

Insider

Positions held

SinceUntil

Sandra Leung

General Counsel	2006-12-31	2025-05-04
Corporate Secretary	2006-12-31	2014-12-31

Vicki Sato

Director/Board Member	2006-07-10	2021-05-03
Independent Dir/Board Member	2006-07-10	2021-05-03

Michael Grobstein

Director/Board Member	2007-03-05	2020-05-04
Independent Dir/Board Member	2007-03-05	2020-05-04

John E. Elicker

Investor Relations Contact	1999-12-31	2020-03-30
Public Communications Contact	1999-12-31	2020-01-05

Joseph C. Caldarella

Comptroller/Controller/Auditor

2009-12-31

2018-02-14

Laurie Glimcher

Director/Board Member	1996-12-31	2017-07-20
Independent Dir/Board Member	1996-12-31	2017-07-20

Lamberto Andreotti

Director/Board Member	2008-12-31	2014-12-31
Chief Executive Officer	2010-05-03	2015-05-04
Chairman	2014-12-31	2017-05-01
Chief Operating Officer	2008-04-30	2010-04-30
Corporate Officer/Principal	1997-12-31	2008-04-30

James Cornelius

Chief Executive Officer	2006-09-11	2010-05-03
Chairman	2006-08-31	2015-05-04
Independent Dir/Board Member	2004-12-31	2015-05-04
President	2006-08-31	2013-02-13

John E. Celentano

Human Resources Officer	2011-05-12	2012-10-07
Public Communications Contact	2011-05-12	2012-10-07
Corporate Officer/Principal	1999-12-31	2013-06-30

Charles Sigal

Director/Board Member	2011-03-02	2013-05-31
Chief Tech/Sci/R&D Officer	2004-09-30	2013-05-31

Robert Williams

Director/Board Member	2006-09-10	2013-05-30
Independent Dir/Board Member	2011-05-11	2013-05-30

Louis J. Freeh

Director/Board Member	2004-12-31	2013-03-06
Independent Dir/Board Member	2011-05-10	2013-03-06

Anthony Hooper

Chief Operating Officer	2011-05-12	2011-10-19
Corporate Officer/Principal	1995-12-31	2011-05-12

Leif Valdemar Johansson

Director/Board Member	1997-12-31	2011-09-19
Independent Dir/Board Member	2011-05-10	2011-09-19

Carlo de Notaristefani

Corporate Officer/Principal

2003-12-31

2011-06-30

Blaine Davis

Corporate Officer/Principal

2004-12-31

2008-04-30

Stephen E. Bear

Human Resources Officer

2000-12-31

2008-03-30

Richard K. Willard

General Counsel

2004-12-31

2007-05-10

Andrew Bonfield

Director of Finance/CFO

2001-12-31

2006-12-31

David J. Helfgott

Chief Operating Officer	2006-11-14	-
President	2006-11-14	-

Louis Sullivan

Director/Board Member

2006-05-01

Louis Gerstner

Director/Board Member	-	2006-05-01
Independent Dir/Board Member	-	2006-05-01

Donald Hayden

Corporate Officer/Principal

1980-12-31

2005-12-31

John L. McGoldrick

General Counsel

1994-12-31

2005-09-30

Robert T. Zito

Public Communications Contact

2004-05-31

Edward M. Dwyer

Treasurer

2003-12-31

Dean Mitchell

Corporate Officer/Principal

2000-12-31

2003-12-31

Juan Sanchez

Corporate Officer/Principal

2003-10-31

Richard L. Wolgemuth

General Counsel

2002-12-31

Carol Marino

Corporate Officer/Principal

1995-08-31

2002-12-31

Fabio M. Benedetti

Chief Tech/Sci/R&D Officer

1999-06-30

2002-04-30

Steven E. Benner

Chief Tech/Sci/R&D Officer

1994-12-31

2001-12-31

Stacey M. Lituchy

Corporate Officer/Principal

2001-12-30

Gary Dickinson

Human Resources Officer

1996-12-31

2001-03-31

David L. Zabor

Corporate Officer/Principal

2000-12-31

Stacey Latuche

Portfolio Manager-Equities

2000-12-30

Robert L. Simon

General Counsel

1986-12-31

2000-06-30

Jaisim Shah

Sales & Marketing

1997-06-30

2000-06-30

Ronald Pepin

Chief Tech/Sci/R&D Officer

1990-02-28

2000-06-30

Myrtle Potter

Corporate Officer/Principal

1995-12-31

2000-04-30

Andrew Bodnar

Chief Tech/Sci/R&D Officer

1999-12-31

Kin Yip Leung

Corporate Officer/Principal

1989-12-31

1999-01-31

Nicole Onetto

Chief Tech/Sci/R&D Officer

1991-06-30

1997-04-30

Kenneth Anderson

Sales & Marketing

1979-12-31

1996-12-31

Joachim von Roy

Corporate Officer/Principal

1996-12-31

William Scott

Corporate Officer/Principal

1989-12-31

1996-12-30

N. Coles

Corporate Officer/Principal

1995-12-31

Robert B. Ross

Corporate Officer/Principal

1990-12-31

1994-12-30

Patrick J. Fortune

Corporate Officer/Principal

1991-11-30

1994-07-31

Mark J. Carvlin

Sales & Marketing

1988-12-31

1993-12-30

Lawrence Hamilton

Chief Administrative Officer	1984-12-31	1993-07-31
Human Resources Officer	1984-12-31	1993-07-31

Barry Wilson

Corporate Officer/Principal

1979-12-31

1992-12-31

Henry Y. Pan

Corporate Officer/Principal

1984-12-31

1991-12-31

Steven Ratoff

Director of Finance/CFO	1974-12-31	1990-12-31
Corporate Officer/Principal	1974-12-31	-

George Zavoico

Corporate Officer/Principal

1987-12-31

Robert A. Fildes

Chief Operating Officer

1974-12-31

1979-12-31

Arthur C. Louie

Corporate Officer/Principal

Guo Wei Wang

Corporate Officer/Principal

Jerry Frantz

Sales & Marketing

Anthony Plohoros

Public Communications Contact

Jay Moorin

Corporate Officer/Principal

Mark Gleason

Corporate Officer/Principal

Greg W. Cashman

Director of Finance/CFO

1995-12-30

James A. McClintic

Sales & Marketing

Salvatore Forenz

Director/Board Member

Jonas Wang

Corporate Officer/Principal

Andrew Forman

Corporate Officer/Principal

Andrew P. Savadelis

Treasurer

H. Perry Fell

Corporate Officer/Principal

Lori A. Klimach

Sales & Marketing

Alexander MacPherson

Corporate Officer/Principal

Paul Karr

Comptroller/Controller/Auditor

John L. Skule

Public Communications Contact

James B. Palmer

Chief Tech/Sci/R&D Officer	-	-
President	-	-

Steven Girgenti

Corporate Officer/Principal

Ronald Thiboutot

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	20
Female	8

Of which Executive Committee

Male	6
Female	4

Of which Directors

Male	9
Female	2

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Yes

Conforme à la finance Islamique

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 69.1% of net sales.

Employees

32,500

Sector

Pharmaceuticals

Calendar

Apr. 30 - Earnings release - Q1 2026

More about the company